Neuroprotective agents in Parkinson's disease: clinical evidence and caveats

Neurol Clin. 2004 Oct;22(3 Suppl):S1-S17. doi: 10.1016/j.ncl.2004.07.002.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antiparkinson Agents / adverse effects
  • Antiparkinson Agents / therapeutic use*
  • Brain / drug effects
  • Clinical Trials as Topic
  • Drug Therapy, Combination
  • Humans
  • Neuroprotective Agents / adverse effects
  • Neuroprotective Agents / therapeutic use*
  • Parkinson Disease / drug therapy*
  • Treatment Outcome

Substances

  • Antiparkinson Agents
  • Neuroprotective Agents